Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro.
about
A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese populationMolecular genetics of coronary artery diseaseAdvances in the genetic basis of coronary artery diseaseHigh shear stress induces atherosclerotic vulnerable plaque formation through angiogenesisNatural single amino acid polymorphism (F19Y) in human galectin-8: detection of structural alterations and increased growth-regulatory activity on tumor cellsHuman galectin-2 interacts with carbohydrates and peptides non-classically: new insight from X-ray crystallography and hemagglutinationPADB: published association databaseLong-term outdoor air pollution and DNA methylation in circulating monocytes: results from the Multi-Ethnic Study of Atherosclerosis (MESA)Tumor necrosis factor-α and lymphotoxin-α mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart StudyGenome-wide association study of coronary artery disease in the JapaneseIL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality.Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.Age-related susceptibility to severe malaria associated with galectin-2 in highland PapuansEndothelial galectin-1 binds to specific glycans on nipah virus fusion protein and inhibits maturation, mobility, and function to block syncytia formation.Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibshipsRecent developments in genomewide association scans: a workshop summary and reviewA genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart StudyInterrelationships between ALOX5AP polymorphisms, serum leukotriene B4 level and risk of acute coronary syndromeGenome-wide association study of coronary artery disease.Association between LGALS2 3279C>T and coronary artery disease: A case-control study and a meta-analysis.A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.Platelets and galectinsLack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations.Genetics of stress response and stress-related disorders.Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization.The genetics of heart attackGenomic and proteomic determinants of lower extremity revascularization failure: rationale and study designRegulatory roles of galectins in the immune response.Galectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox.Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease.Genetic and genomic insights into the molecular basis of atherosclerosis.Genetic markers of cardiovascular disease in rheumatoid arthritis.When galectins recognize glycans: from biochemistry to physiology and back againThe coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders.Calycosin‑7‑O‑β‑D‑glucoside attenuates ischemia‑reperfusion injury in vivo via activation of the PI3K/Akt pathway.Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?Genetic susceptibility to myocardial infarction and coronary artery disease.Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.
P2860
Q24297364-0EA5F5FC-9A45-4F50-A8F6-B1F7EDFAC19FQ24674808-0445354B-A36D-4F05-A6C3-27B88C0A700EQ24682029-C51D6055-2F7B-49F0-A3BC-6BA552219A9BQ26740033-1BBAF228-830B-4F12-A49C-FF57DF3B46C0Q27688879-164EC9A6-B5A1-4FBE-8DE6-38B439EE0905Q27727738-1454BD29-62BF-46EE-AB26-7557560B7B4DQ28221773-0D52454F-BB3A-44D7-AD17-76E610330B76Q28395480-B36C160B-57DC-4AD4-A1E5-F8A79C511538Q28488447-DD89D4C5-4D7C-41EC-BD58-1E9A8AF9732DQ28943280-89E40BE9-3698-44C5-B7DD-D9D3B33863E2Q28943353-9674B250-FB6F-4280-AF5D-95F1C776CA26Q30448616-4F4DBBA1-443E-4D21-B945-E893DB32AFE7Q33267324-AEF4B1CF-DDFD-404C-B9FB-5C15E068731FQ33300816-DB3F26DA-74FF-444A-963A-16362BEC8F85Q33586454-6437767A-450B-4B3C-8A04-DBE1EFD3B683Q33640112-51401C0E-DCD4-44DB-9A4A-7BE70B4E391CQ33689539-BAD77ABB-A4BF-4651-9980-F9F700E89879Q34021104-3F664EB8-B895-42ED-A095-FC5DD978E346Q34137411-596CC373-9584-4532-B2E0-C8412871C8F6Q34165844-B26166B8-E682-418F-9BF4-CF51C31CF197Q34218772-F3A32BC7-E1C5-4C24-94BF-2FC89F17E62CQ34265297-7193B272-3091-4F98-9DB0-C2754BA8ABC2Q34297619-73C5791E-0608-4F04-B633-AB5B735126E5Q34385152-A96662A5-8320-4EAE-8D91-C32F33550ABFQ34627081-AD925470-1EDD-4837-861B-E1020CB25CA2Q35236890-CB930922-AC5E-4A9D-B38C-C6052F124148Q35626327-8BE95A81-92C7-4287-BFBD-CA4FE87F0025Q35770844-8C208E65-824C-4CA5-8B27-45624FC112CFQ35944843-4222C379-4D19-43A2-8864-2FA42A8F08B2Q36073653-CF745258-4E67-49D8-A2BF-658994E134BDQ36093631-58F1A0E8-D3D9-45A5-8740-B50428400BBCQ36135442-00F6408D-0EDD-4F0E-8452-83D62E3D7176Q36155114-08350E7E-5F65-4798-A806-54A3C6470447Q36165202-AFD2E438-E51A-4ABA-A0BA-A87C2E1360D9Q36196146-B8CFC0B1-A0A2-45D5-BC87-4B9831D20367Q36292670-4B1D9C5C-72BD-4677-A2A5-DD7C6828B2C6Q36390251-8A1AEA6F-30DC-4F02-8F2F-D27786964718Q36580332-2DDBF34F-F2C5-443D-A7AF-BDBFCA5E608CQ36599259-FE80C49B-9CF8-4D3F-BFD3-18E7D6403E49Q36741513-45EA86BB-171F-4419-8019-E95441DD5ADB
P2860
Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@ast
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@en
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@nl
type
label
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@ast
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@en
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@nl
prefLabel
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@ast
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@en
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@nl
P2093
P50
P356
P1433
P1476
Functional variation in LGALS2 ...... oxin-alpha secretion in vitro.
@en
P2093
Akihiro Sekine
Aritoshi Iida
Hideyuki Sato
Hiroshi Sato
Katsumi Inoue
Masakiyo Nobuyoshi
Masatsugu Hori
Yozo Ohnishi
Yusuke Nakamura
P2888
P356
10.1038/NATURE02502
P407
P577
2004-05-01T00:00:00Z
P5875
P6179
1019091080